As of 2025-11-04, the Relative Valuation of Entheon Biomedical Corp (ENBI.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.10 CAD, the upside of Entheon Biomedical Corp based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-10-28 | -3.39 |
| 2025-10-27 | -3.39 |
| 2025-10-24 | -3.39 |
| 2025-10-23 | -3.03 |
| 2025-10-20 | -3.21 |
| 2025-10-16 | -2.67 |
| 2025-10-15 | -2.50 |
| 2025-10-14 | -3.03 |
| 2025-10-09 | -2.85 |
| 2025-10-06 | -2.50 |
| 2025-10-03 | -3.21 |
| 2025-10-01 | -3.21 |
| 2025-09-30 | -3.21 |
| 2025-09-29 | -3.21 |
| 2025-09-23 | -3.03 |
| 2025-09-22 | -2.85 |
| 2025-09-18 | -3.57 |
| 2025-09-16 | -3.03 |
| 2025-09-15 | -3.03 |
| 2025-09-05 | -3.57 |
| 2025-09-04 | -3.21 |
| 2025-09-03 | -3.21 |
| 2025-09-02 | -3.21 |
| 2025-08-29 | -3.39 |
| 2025-08-28 | -3.39 |
| 2025-08-21 | -3.39 |
| 2025-08-19 | -3.57 |
| 2025-08-18 | -3.39 |
| 2025-08-15 | -3.39 |
| 2025-08-13 | -3.57 |
| 2025-08-12 | -3.57 |
| 2025-08-07 | -3.39 |
| 2025-08-06 | -3.74 |
| 2025-08-05 | -3.74 |